Cargando…
Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis
BACKGROUND: Reperfusion of ischemic tissue has adverse impact on the myocardium. Dexmedetomidine (Dex) is a α2-adrenergic receptor (α2-AR) agonist with sedative and analgesic effects. Macrophage migration inhibition factor (MIF) is a pressure-regulating cytokine and is responsible for inflammatory a...
Autores principales: | Chen, Siyu, Li, Aimei, Wu, Jianjiang, Huang, Yidan, Zou, Tiantian, Tailaiti, Taiwangu, Wang, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472426/ https://www.ncbi.nlm.nih.gov/pubmed/36104681 http://dx.doi.org/10.1186/s12871-022-01825-z |
Ejemplares similares
-
Dexmedetomidine Leads to the Mitigation of Myocardial Ischemia/Reperfusion-Induced Acute Lung Injury in Diabetic Rats Via Modulation of Hypoxia-Inducible Factor-1α
por: Chen, Siyu, et al.
Publicado: (2022) -
Ischemic Postconditioning Attenuates Myocardial
Ischemia-Reperfusion-Induced Acute Lung Injury by Regulating Endoplasmic
Reticulum Stress-Mediated Apoptosis
por: Li, Aimei, et al.
Publicado: (2023) -
Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
por: Yang, Ke, et al.
Publicado: (2023) -
Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020) -
Retraction: Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
Publicado: (2022)